Article
Consensus recommendations for the off-label use of recombinant human factor VIIa (NovoSeven®) therapy
Aryeh Shander,Lawrence T. Goodnough,Thomas A Ratko,Karl Matuszewski,Stephen M. Cohn,Michael N. Diringer+6 more-2005-11-01
51
Chat with Paper
AI Agents for this Paper
No abstract available for this paper.
Keywords
Recombinant factor VIIaFactor VIIaMedicineRecombinant DNASurgeryInternal medicineTissue factorChemistry
Chat
Click to start Chat